Texas medical school fails to deliver on founding promise

Texas taxpayers wanted to help low-income people get health care. Instead, they're funding a medical school at a wealthy university.

January 2, 2024 Check out STAT+

Sponsored By

Ilana Panich-Linsman for STAT STAT+ | Texas taxpayers wanted to help the poor get health care. Instead, they're funding a medical school at a wealthy university Dell Medical School in Austin was financed as a way to improve health care access for the poor. Activists, lawmakers want to know why that never happened. By Rachel Cohrs STAT+ | Here's who's profiting the most in health care Ahead of the J.P. Morgan Healthcare Conference, STAT looked at who profits the most in health care. More surprising might be who doesn't. By Tara Bannow and Brittany Trang STAT+ | The biotech scorecard for the first quarter: 17 stock-moving events to watch There's lots to watch in the industry in the months ahead, including readouts on Vertex's pain drug and Acadia's anti-psychotic therapy. By Adam Feuerstein Public Citizen STAT+ | Consumer health advocate Sid Wolfe was a thorn in the side. We're all the better as a result Sid Wolfe, who died Monday, specialized in taking on the Food and Drug Administration and many of the world's biggest drug manufacturers. By Ed Silverman STAT+ | 2024 could be a turning point for the regulation of AI in health care In health care, predictive AI models may have to explain how their systems were developed, and prove their safety, reliability, and fairness. By Casey Ross and Katie Palmer STAT+ | A single drug and multiple study failures leave Anavex with nothing but cash The latest study outcome was never in doubt, so the only surprise from the readout was Anavex's lame attempt at damage control. By Adam Feuerstein Brandon Bell/Getty Images STAT+ | Inside Ascension's legal fight with a Texas agency over caring for the poor Ascension is locked in a legal battle with an Austin agency over whether poor patients are actually getting the care they're entitled to. By Rachel Cohrs Opinion: Today's at-home microbiome testing industry is fraught with snake oil Many patients come to my office having unnecessarily suffered while they tried to optimize their microbiome based on ambiguous test results. By Sameer Berry

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser